LncRNA Information | ||||||
---|---|---|---|---|---|---|
ID | EL0655 | Name | LINC00313 | Aliases | C21orf84; CH507-42P11.5; NCRNA00313 | |
Species | Homo sapiens | Chromosome | 21 | Start site | 43462094 | |
End site | 43479534 | Chain | minus | Exon NO. | 4 | |
Assembly | Ensembl Release 89 | Class | lincRNA | NCBI accession | NR_026863 | |
Ensembl | ENSG00000185186 | Sequence |
Disease | |||||||||
---|---|---|---|---|---|---|---|---|---|
Disease | Method | Sample | Expression pattern | Dysfunction type | Description | PMID | Source | ||
lung cancer | microarray, qRT-PCR | tissues from 181 early-stage lung cancer patients | up-regulated | expression | Notably, a novel lncRNA, LINC00313, was highly expressed in both T2- and N1-stage lung cancers. On the other hand, LINC00313 was also upregulated in lung cancer and metastasized lung cancer tissues, compared with adjacent lung tissues and primary lung cancer tissues. LINC00313 could be a biomarker for lung cancer. | 26178480 | |||